Top Markets
#1 GEKKO GEKKO +53.94%
#2 Helium Helium +47.23%
#3 Pons Pons +25.55%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +15.91%
#6 Collect on Fanable Collect on Fanable +14.24%
#7 o1.exchange o1.exchange +14.04%
#8 Ontology Gas Ontology Gas +11.63%
#9 Nockchain Nockchain +11.47%
#10 OpenGradient OpenGradient +10.61%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
Guangzhou Wondfo Biotech Co.,Ltd Guangzhou Wondfo Biotech Co.,Ltd

Guangzhou Wondfo Biotech Co.,Ltd

300482
Rank in Stocks #9000
Guangzhou Wondfo Biotech Co.,Ltd operates as a biotechnology enterprise,... Guangzhou Wondfo Biotech Co.,Ltd operates as a biotechnology enterprise, specializing in the research, development, production, and distribution of point-of-care testing (POCT) products. The company additionally provides rapid diagnostic tools and comprehensive solutions for managing chronic diseases. Its product catalog features an array of rapid test kits, addressing conditions like COVID-19, substance abuse, certain cancers, infectious diseases, fertility, and sexually transmitted infections. Furthermore, Wondfo Biotech offers immunofluorescence devices designed to identify cardiovascular conditions, inflammatory markers, kidney damage, hormonal imbalances (including sex hormones and thyroid function), diabetes, and specific tumor indicators. The firm also supplies analytical instruments, such as blood gas, optical coagulation, and dry chemistry analyzers. Established in 1992, the company's main operations are based in Guangzhou, China.
Share Price
$2.39
Last synced: 2026-08-28
Market Cap
$1.12B
Change (1 day)
0.24%
Change (1 year)
-23.68%
Country
CN
Trade Guangzhou Wondfo Biotech Co.,Ltd (300482)

Category

Healthcare
Revenue for Guangzhou Wondfo Biotech Co.,Ltd (300482)
Revenue in Aug 2026 TTM: 0
According to Guangzhou Wondfo Biotech Co.,Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Guangzhou Wondfo Biotech Co.,Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $46.34B -
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $25.11B -
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 - -
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $2.71B -
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $4.55B -
US